PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)

MCL and WTB are the guarantors of the research findings presented. MCL, EPW, CAH, LAC, CMP, MJE, and WTB were involved in the study concept and design. MCL, BNP, EPW, CAH, and WTB were involved in the data analysis and interpretation. All the authors contributed to data collection and assembly. All the authors provided final manuscript approval for submission